Sponsor
Henan Provincial People's Hospital
Clinical research sponsor
How to interpret these research links
Connected source recordsThe exact organization name Henan Provincial People's Hospital appears in 44 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.
Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.
Advertisement
Clinical trials
44 shownCOPD-PTB Screening Trial in Henan, ChinaNCT07706972 · lead sponsor · 2026-07-20
NOT_YET_RECRUITINGComparing BTVA and MWA in COPD With Early Lung Cancer: Efficacy and SafetyNCT06929390 · lead sponsor · 2025-05-01
NOT_YET_RECRUITINGEffect of CYP2D6*10 Gene Mutation on Perioperative Precision Analgesia of Oxycodone in Elderly PatientsNCT07484867 · lead sponsor · 2025-01-01
COMPLETEDDriving Pressure-guided Positive End-expiratory Pressure to Prevent Postoperative Atelectasis in Obese Children: a Prospective, Randomized Controlled Clinical TrialNCT06471491 · lead sponsor · 2024-09-11
COMPLETEDThe Effect of Mask Combined With High Flow Oxygen on Preoxygenation During Induction of General Anesthesia in Obese PatientsNCT06562660 · lead sponsor · 2024-05-01
UNKNOWNThe Aim of This Study is to Investigate the Correlation Between the Severity of Glaucoma and Corneal Biomechanics as Well as Anterior Chamber Parameters.NCT06340061 · lead sponsor · 2022-10-20
UNKNOWNEfficacy and Safety of Microwave Ablation Combined With Camrelizumab and Chemotherapy in Patients With Advanced Non-small Cell Lung Cancer: a Multicenter, Open, Prospective StudyNCT05532527 · lead sponsor · 2022-09-20
UNKNOWNStudy of Anlotinib Combined With Pemetrexed in Patients With Advanced Nonsquamous NSCLCNCT03778138 · lead sponsor · 2019-01-01
UNKNOWNStudy on the Mechanism of Regulating Gut Microbiome in Obese People by Regulating Brain-gut Axis With Fast DietNCT04691583 · lead sponsor · 2018-04-11
COMPLETEDConmana Combined With Thalidomide to Treat NSCLCNCT02778893 · lead sponsor · 2016-03-01
UNKNOWNClinical Study of Three Plus Two Type Early Diagnosis of Pulmonary Nodules in Medical Internet of ThingsNCT02773992 · lead sponsor · 2015-08-01
UNKNOWNCompare to the Safety of Efavirenz and Nevirapine in Treating HIV Positive Patients With Mild Baseline Liver Function Test Impairment, and/or Hepatitis B or Hepatitis C Co-infectionNCT01273142 · lead sponsor · 2011-01-01
UNKNOWNRomiplostim N01 Plus ATRA for Persistent Isolated Chemotherapy-Induced Thrombocytopenia After Complete Remission of Gynecologic, Breast, or Lung Solid TumorsNCT07586826 · collaborator · 2025-12-22
RECRUITINGChronic Airway Disease and Multimorbidity CohortNCT06798077 · collaborator · 2025-02-01
RECRUITINGThe Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment SystemNCT07136025 · collaborator · 2025-02-01
RECRUITINGClinical Applicantion of Multi-Tracer PET/MR Imaging in Neurological Disorders/DiseaseNCT06092125 · collaborator · 2022-10-01
RECRUITINGDetection of Alzheimer's Disease (AD)-Related Seeds for AD DiagnosisNCT04850053 · collaborator · 2020-08-26
RECRUITINGChina Health Big DataNCT03699228 · collaborator · 2017-12-01
RECRUITINGThe Chinese Familial Alzheimer's NetworkNCT03657732 · collaborator · 2005-01-10
RECRUITINGDual GIP/GLP-1 Receptor Agonist in Obese Women Before Frozen Embryo TransferNCT07811895 · collaborator · 2026-09-01
NOT_YET_RECRUITINGMulticenter Study on Early Arterial Changes in Prediabetic Patients Evaluated by Ultra-High-Frequency UltrasoundNCT07271745 · collaborator · 2025-12-15
NOT_YET_RECRUITINGA Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization (TACE) Combined With Iparomlimab and Tuvonralimab Injection and Bevacizumab Injection for the Treatment of Unresectable, Non-Metastatic Hepatocellular Carcinoma (HCC)NCT07128251 · collaborator · 2025-08-20
NOT_YET_RECRUITINGA Randomized Trial of Six-Channel RF Ablation System for Renal Denervation in Uncontrolled Hypertension and Chronic Kidney DiseaseNCT07130955 · collaborator · 2025-08-08
ENROLLING_BY_INVITATIONThe Severity Assessment Model for AECOPD With Combination of Disease and SyndromeNCT06918353 · collaborator · 2025-04-01
NOT_YET_RECRUITINGA Multicenter Clinical Study of Echocardiographic Assessment of Right Heart Function and Implications of Prognosis in DiabetesNCT04964713 · collaborator · 2023-12-01
NOT_YET_RECRUITINGfMRI-guided Transcranial Magnetic Stimulation Treatment for Parkinson's DiseaseNCT06734676 · collaborator · 2023-05-29
COMPLETEDLung Cancer Diagnosis by Detecting Epigenetic Imprinting Alterations in Bronchoalveolar LavageNCT05707585 · collaborator · 2023-01-29
UNKNOWNPrevention of PONV With Traditional Chinese MedicineNCT05375721 · collaborator · 2022-09-23
UNKNOWNEchocardiographic Assessment of the Impact of Diabetes and Prognostic Analysis of Heart TransplantationNCT04976517 · collaborator · 2021-08-01
UNKNOWNEarly Health Warning Intervention in Tobacco ControlNCT04996329 · collaborator · 2021-04-21
UNKNOWNThe Effectiveness and Safety of Resective Epilepsy Surgery for TRENCT04198181 · collaborator · 2019-12-12
ACTIVE_NOT_RECRUITINGStudy on the Correlation Between TCM Syndrome, Inflammatory Phenotype and Biomarker of Bronchial AsthmaNCT04128111 · collaborator · 2019-10-07
UNKNOWNA Study on the Treatment of Parkinson's Disease With Autologous Neural Stem CellsNCT03815071 · collaborator · 2019-02-01
UNKNOWNApplication of Deep-learning and Ultrasound Elastography in Opportunistic Screening of Breast CancerNCT03851497 · collaborator · 2019-01-01
COMPLETEDDiagnostic and Monitoring Significance of ctDNA Methylation Analysis by NGS in Benign and Malignant Pulmonary NodulesNCT03651986 · collaborator · 2018-11-26
UNKNOWNPredictive Value of Inflammatory Biomarkers and FEV1 for COPDNCT03532893 · collaborator · 2018-03-03
COMPLETEDWarm Acupuncture for Breast Cancer Related LymphedemaNCT03373474 · collaborator · 2018-01-18
COMPLETEDStudy on the Etiology, Risk Factors and Pathogenesis of COPD Based on Clinical BioinformaticsNCT05069194 · collaborator · 2017-12-10
UNKNOWNThyroid Hormone Replacement for Subclinical Hypothyroidism and Chronic Heart Failure (ThyroHeart-CHF)NCT03096613 · collaborator · 2017-04-18
UNKNOWNMulti-center Imaging Genetics Studies in ChinaNCT02681822 · collaborator · 2015-11-01
UNKNOWNChemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung AdenocarcinomaNCT02621333 · collaborator · 2015-10-01
TERMINATEDRisk Stratification of Patients Using the Lung Cancer Biomarker Panel in ChinaNCT01928836 · collaborator · 2012-10-01
COMPLETEDStudy of Qiliqiangxin Capsule to Treat Dilated CardiomyopathyNCT01293903 · collaborator · 2012-01-01
COMPLETEDThe Efficacy and Safety of Salmeterol/Fluticasone Propionate vs Atropium/Albuterol in Patients COPDNCT01243788 · collaborator · 2009-07-01
UNKNOWNDrugs studied in this sponsor's trials
5 mapped RxNorm conceptsThese drug records are connected through ClinicalTrials.gov studies listing Henan Provincial People's Hospital as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.
bevacizumab1
levothyroxine1
oxycodone1
placebo1
thalidomide1
bevacizumab RxCUI 253337 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
levothyroxine RxCUI 10582 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
oxycodone RxCUI 7804 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
placebo RxCUI 8375 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting
1 trial
thalidomide RxCUI 10432 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting
1 trial
Sponsor roles
collaborator32
lead sponsor12
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.